KIORA PHARMACEUTICALS, INC. (KPHMW) Net margin 2016–2024
KIORA PHARMACEUTICALS, INC. (KPHMW) net profit margin by fiscal year — reported net income divided by reported revenue.
22.4%FY2024 · since FY2016: -1993.8% → 22.4%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2024 | 22.4% | — |
| FY2020 | -56901.7% | -56637.4 pp |
| FY2019 | -264.2% | +390.0 pp |
| FY2018 | -654.2% | +2589.3 pp |
| FY2017 | -3243.5% | -1249.8 pp |
| FY2016 | -1993.8% | — |
Net margin = reported net income ÷ reported revenue for the same fiscal year. Loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice
More KPHMW financial trends
KPHMW RevenueKPHMW Net incomeKPHMW Gross profitKPHMW Gross marginKPHMW Operating incomeKPHMW Operating marginKPHMW Operating cash flowKPHMW Free cash flowKPHMW Capital expendituresKPHMW Return on equityKPHMW Stock buybacksKPHMW Dividends paidKPHMW Total assetsKPHMW Total liabilitiesKPHMW Shareholders’ equityKPHMW overview →